Gene editing: The next frontier in America’s abortion wars
By Sarah Karlin,
Politico
| 02. 16. 2016
[cites CGS' Marcy Darnovsky]
Untitled Document
Longtime combatants find themselves on the same side when it comes to manipulating the DNA of human embryos.
That may seem like an idea from a sci-fi flick, but it’s already here. The gene-editing technique is already used in research and has the potential to modify human DNA with unprecedented ease in the not-too-distant future. British regulators approved limited experiments in human embryos earlier this month.
The technology holds promise to cure diseases like cystic fibrosis or sickle cell and even revive extinct species. But critics fear it could also be harnessed to craft “designer babies,” who are more intelligent, beautiful or athletic and to “edit” embryonic cells to change an inherited trait forever.
Those dystopian prospects have aligned U.S. groups long at odds: The anti-abortion Susan B. Anthony List, Family Research Council and the Center for Bioethics and Culture oppose gene editing in embryos. So do abortion rights groups like Our Bodies Ourselves and the leadership of the Pro Choice Alliance for Responsible Research, albeit for very different reasons.
They’re not alone in raising concerns. Scientists...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...